Keefe Bruyette raised the firm’s price target on Dave (DAVE) to $295 from $250 and keeps an Outperform rating on the shares. Dave reported a strong quarter and provided 2026 guidance that was well above consensus on revenue and EBITDA, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DAVE: